Announce Date | 04/24/2025 |
EPS Normalized Actual | $1.2 (Beat by $0.09) |
EPS GAAP Actual | $1.2 (Beat by $0.09) |
Revenue Actual | $2.6486B |
Revenue Surprise | Beat by $2648.6M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.77803 |
EPS GAAP Estimate | $0.77803 |
Revenue Estimate | $2.317888458B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 6.67773 | 13.34 | 6.37631 | 6.98466 | 2 |
Dec 2026 | 3.97043 | 22.43 | 3.88319 | 4.13794 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.74 | -0.01333 | 2.6486B | 16.97% | 402.98M |
FQ4 2024 (Dec 2024) | 1.3 | 1.3 | 2.5457B | 13.59% | 2545.7M |
FQ3 2024 (Sep 2024) | 0.78 | 0.78 | 2.51961B | 18.9% | 2519.61M |
FQ2 2024 (Jun 2024) | 0.84 | 0.84 | 2.39141B | 18.9% | 2391.41M |
FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 2.19903B | 16.43% | 2199.03M |
FQ4 2023 (Dec 2023) | 0.72 | 0.72 | 2.19966B | 7.14% | 2199.66M |
FQ3 2023 (Sep 2023) | 0.67 | 0.67 | 2.0433B | 5.87% | 2043.3M |
FQ2 2023 (Jun 2023) | 0.46 | 0.46 | 1.9394B | 11.46% | 1939.4M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.77803
Consensus Revenue Estimates
2.317888458B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.62449 | -- | 1.61361 | 1.6352 | 1 |
FQ2 2027 (Jun 2027) | 1.51384 | -- | 1.5037 | 1.52382 | 1 |
FQ1 2027 (Mar 2027) | 1.47486 | -- | 1.45977 | 1.49952 | 2 |
FQ4 2026 (Oct 2026) | 0.9502 | -- | 0.94088 | 0.963 | 1 |
FQ3 2026 (Jul 2026) | 0.96694 | -- | 0.95745 | 0.97997 | 1 |
FQ2 2026 (Jun 2026) | 0.8608 | -- | 0.8445 | 0.88306 | 1 |
FQ1 2026 (Mar 2026) | 0.98809 | 25.11 | 0.9667 | 1.00921 | 3 |
FQ4 2025 (Oct 2025) | 0.92037 | -41.25 | 0.91134 | 0.93277 | 2 |
FQ3 2025 (Jul 2025) | 0.90868 | 14.16 | 0.89977 | 0.92092 | 2 |
FQ2 2025 (Jun 2025) | 0.77803 | -7.96 | 0.7633 | 0.79815 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.43B | -- | 3.41B | 3.45B | 1 |
FQ2 2027 (Jun 2027) | 3.25B | -- | 3.23B | 3.26B | 1 |
FQ1 2027 (Mar 2027) | 3.19B | -- | 3.17B | 3.23B | 2 |
FQ4 2026 (Oct 2026) | 2.69B | -- | 2.67B | 2.71B | 2 |
FQ3 2026 (Jul 2026) | 2.65B | -- | 2.63B | 2.68B | 2 |
FQ2 2026 (Jun 2026) | 2.4B | -- | 2.37B | 2.45B | 2 |
FQ1 2026 (Mar 2026) | 2.59B | -2.34 | 2.54B | 2.63B | 1 |
FQ4 2025 (Oct 2025) | 2.52B | -1.16 | 2.5B | 2.54B | 1 |
FQ3 2025 (Jul 2025) | 2.49B | -1.23 | 2.47B | 2.51B | 1 |
FQ2 2025 (Jun 2025) | 2.32B | -3.17 | 2.28B | 2.36B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.75333 | 0.74 | -0.01333 | -1.8% |
FQ4 2024 (Dec 2024) | 1.3 | 1.3 | 100% | |
FQ3 2024 (Sep 2024) | 0.78 | 0.78 | 100% | |
FQ2 2024 (Jun 2024) | 0.84 | 0.84 | 100% | |
FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 100% | |
FQ4 2023 (Dec 2023) | 0.72 | 0.72 | 100% | |
FQ3 2023 (Sep 2023) | 0.67 | 0.67 | 100% | |
FQ2 2023 (Jun 2023) | 0.46 | 0.46 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $2.25B | $2.65B | $402.98M | 15.21% |
FQ4 2024 (Dec 2024) | $0B | $2.55B | $2545.7M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.52B | $2519.61M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.39B | $2391.41M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.2B | $2199.03M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.2B | $2199.66M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.04B | $2043.3M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.94B | $1939.4M | 100% |